title: Palatal swelling as the first and only manifestation of extranodal follicular non-Hodgkin lymphoma: a case presentation.
abstract: Non-Hodgkin lymphomas (NHLs) in the head and neck region are malignant lymphoid neoplasms that usually originate from B-lymphocytic cell lines. Primary extranodal manifestations of this hematolymphoid tumor in the oral cavity are rare and involve the maxillary jaw including the palatal soft tissues, the mandible, and gingival tissues in patients between 60 and 70 years of age without sex predilection. This case report of an extra-nodal NHL in the palate of a 75-year-old patient emphasizes the importance of accurate clinical, radiographic, and histologic diagnostic procedures to avoid delayed diagnosis or inappropriate treatment strategies. Chemotherapy, radiotherapy, or a combination of the two with a regular clinical and hemic follow-up is recommended.
authors.affiliation: Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, and Department of ENT, Head and and Neck Surgery, University Hospital, Inselspital, Bern, Switzerland.
authors.forename: Peter
authors.initials: P
authors.lastname: Werder
authors.forename: Hans Jörg
authors.initials: HJ
authors.lastname: Altermatt
authors.forename: Peter
authors.initials: P
authors.lastname: Zbären
authors.forename: Esther
authors.initials: E
authors.lastname: Mueller-Garamvölgyi
authors.forename: Michael M
authors.initials: MM
authors.lastname: Bornstein
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D008297:Male; D010157:Palatal Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D021362:Palate, Hard / Q000473:pathology*; D010160:Palate, Soft / Q000473:pathology; D012074:Remission Induction; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab